SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

BioRestorative Therapies, Inc. – ‘10-Q’ for 6/30/22 – ‘ZIP’

On:  Monday, 8/15/22, at 9:01am ET   ·   For:  6/30/22   ·   Accession #:  1493152-22-22617   ·   File #:  1-37603

Previous ‘10-Q’:  ‘10-Q’ on 5/16/22 for 3/31/22   ·   Next:  ‘10-Q’ on 11/14/22 for 9/30/22   ·   Latest:  ‘10-Q’ on 11/13/23 for 9/30/23   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/15/22  BioRestorative Therapies, Inc.    10-Q        6/30/22   59:4.5M                                   M2 Compliance LLC/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    756K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
10: R1          Cover                                               HTML     72K 
11: R2          Condensed Consolidated Balance Sheets               HTML    104K 
12: R3          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
13: R4          Condensed Consolidated Statements of Operations     HTML     70K 
                (Unaudited)                                                      
14: R5          Condensed Consolidated Statements of Changes in     HTML     77K 
                Stockholders' Equity (Deficit) (Unaudited)                       
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     85K 
                (Unaudited)                                                      
16: R7          Nature of the Organization, Liquidity, and          HTML     34K 
                Business                                                         
17: R8          Summary of Significant Accounting Policies          HTML     87K 
18: R9          Intangible Assets                                   HTML     49K 
19: R10         Accrued Expenses and Other Current Liabilities      HTML     26K 
20: R11         Notes Payable                                       HTML     31K 
21: R12         Stockholders? Equity (Deficit)                      HTML    195K 
22: R13         Commitments and Contingencies                       HTML     26K 
23: R14         Leases                                              HTML     37K 
24: R15         Subsequent Events                                   HTML     23K 
25: R16         Summary of Significant Accounting Policies          HTML    136K 
                (Policies)                                                       
26: R17         Summary of Significant Accounting Policies          HTML     40K 
                (Tables)                                                         
27: R18         Intangible Assets (Tables)                          HTML     49K 
28: R19         Accrued Expenses and Other Current Liabilities      HTML     24K 
                (Tables)                                                         
29: R20         Notes Payable (Tables)                              HTML     23K 
30: R21         Stockholders? Equity (Deficit) (Tables)             HTML    179K 
31: R22         Leases (Tables)                                     HTML     34K 
32: R23         Nature of the Organization, Liquidity, and          HTML     59K 
                Business (Details Narrative)                                     
33: R24         Schedule of Weighted Average Dilutive Common        HTML     34K 
                Shares (Details)                                                 
34: R25         Schedule of Weighted Average Dilutive Common        HTML     20K 
                Shares (Details) (Parenthetical)                                 
35: R26         Summary of Significant Accounting Policies          HTML     41K 
                (Details Narrative)                                              
36: R27         Schedule of Finite Lived Intangible Assets          HTML     41K 
                (Details)                                                        
37: R28         Schedule of Finite Lived Intangible Assets          HTML     32K 
                Amortization Expenses (Details)                                  
38: R29         Schedule of Accrued Expenses and Other Current      HTML     26K 
                Liabilities (Details)                                            
39: R30         Schedule of Notes Payable Activity (Details)        HTML     26K 
40: R31         Notes Payable (Details Narrative)                   HTML     34K 
41: R32         Schedule of Warrant Activity (Details)              HTML     55K 
42: R33         Schedule of Stock Warrants (Details)                HTML     65K 
43: R34         Schedule of Stock Option Granted Assumptions        HTML     29K 
                (Details)                                                        
44: R35         Schedule of Stock Option Activity (Details)         HTML     48K 
45: R36         Schedule of Stock Option by Exercise Price          HTML     60K 
                (Details)                                                        
46: R37         Schedule of Stock Option by Exercise Price          HTML     23K 
                (Details) (Parenthetical)                                        
47: R38         Schedule of Unvested Restricted Stock Units         HTML     29K 
                (Details)                                                        
48: R39         Schedule of Stock Compensation Expense (Details)    HTML     33K 
49: R40         Stockholders? Equity (Deficit) (Details Narrative)  HTML     69K 
50: R41         Commitments and Contingencies (Details Narrative)   HTML     32K 
51: R42         Schedule of Net Lease Cost and Other Supplemental   HTML     33K 
                Lease Information (Details)                                      
52: R43         Schedule of Future Minimum Payments Under           HTML     30K 
                Non-Cancelable Leases for Operating Leases                       
                (Details)                                                        
53: R44         Leases (Details Narrative)                          HTML     31K 
54: R45         Subsequent Events (Details Narrative)               HTML     27K 
57: XML         IDEA XML File -- Filing Summary                      XML    103K 
55: XML         XBRL Instance -- form10-q_htm                        XML   1.10M 
56: EXCEL       IDEA Workbook of Financial Reports                  XLSX     74K 
 6: EX-101.CAL  Inline XBRL Taxonomy Extension Calculation           XML    120K 
                Linkbase Document -- brtx-20220630_cal                           
 7: EX-101.DEF  Inline XBRL Taxonomy Extension Definition Linkbase   XML    388K 
                Document -- brtx-20220630_def                                    
 8: EX-101.LAB  Inline XBRL Taxonomy Extension Label Linkbase        XML    785K 
                Document -- brtx-20220630_lab                                    
 9: EX-101.PRE  Inline XBRL Taxonomy Extension Presentation          XML    611K 
                Linkbase Document -- brtx-20220630_pre                           
 5: EX-101.SCH  Inline XBRL Taxonomy Extension Schema Document --    XSD    108K 
                brtx-20220630                                                    
58: JSON        XBRL Instance as JSON Data -- MetaLinks              284±   387K 
59: ZIP         XBRL Zipped Folder -- 0001493152-22-022617-xbrl      Zip    134K 


‘ZIP’   —   XBRL Zipped Folder — 0001493152-22-022617-xbrl


This is an XBRL Zipped Folder.

        Download this zipped .zip folder
 
Files:brtx-20220630.xsd
brtx-20220630_cal.xml
brtx-20220630_def.xml
brtx-20220630_lab.xml
brtx-20220630_pre.xml
ex31-1.htm
ex31-2.htm
ex32-1.htm
form10-q.htm


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/13/23  BioRestorative Therapies, Inc.    424B5       7/12/23    1:363K                                   M2 Compliance LLC/FA
 4/14/23  BioRestorative Therapies, Inc.    424B2                  1:370K                                   M2 Compliance LLC/FA
 2/07/23  BioRestorative Therapies, Inc.    S-3                    4:283K                                   Certilman Balin … LLP/FA
 9/30/22  BioRestorative Therapies, Inc.    POS AM                 2:759K                                   Certilman Balin … LLP/FA
 8/16/22  BioRestorative Therapies, Inc.    POS AM                 2:764K                                   Certilman Balin … LLP/FA


3 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/30/22  BioRestorative Therapies, Inc.    10-K       12/31/21   92:16M                                    M2 Compliance LLC/FA
11/15/21  BioRestorative Therapies, Inc.    8-K:3,7,9  11/09/21   12:12M                                    Certilman Balin … LLP/FA
12/23/14  BioRestorative Therapies, Inc.    8-K:3,5,9  12/19/14    6:329K                                   Certilman Balin … LLP/FA
Top
Filing Submission 0001493152-22-022617   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 6:01:36.2pm ET